What we’re tracking on 11 December 2019
Today will largely be shaped by how two IPOs will fare in their market debuts. Here at home, Rameda Pharma…
Available in your choice of English or Arabic
Today will largely be shaped by how two IPOs will fare in their market debuts. Here at home, Rameda Pharma…
It’s another day in which the House dominates the nation’s news agenda, but there’s still no sign of the much-awaited…
PRIVATIZATION WATCH- e-Finance could make its EGX debut as early as 1Q2020, chairman says: State-owned payments platform e-Finance is putting…
The House of Representatives had a busy first day back in session yesterday, with a pile of legislation receiving general…
The House of Representatives is back from recess today, and the big question isn’t what’s next on the legislative agenda,…
Is the Saudi Aramco IPO, touted for years as the biggest of all time, actually a wise choice for investors?…
Retail appetite for Rameda’s IPO surgest on last day; offering closing 36.3x oversubscribed: Retail investors poured into Rameda Pharma’s 5%…
It’s the final day for retail investors look to subscribe to Rameda Pharma’s IPO: The penultimate day of Rameda’s retail…
Something went wrong. Please refresh the page and/or try again.
Queue